Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
Dermed Diagnostics, Inc. · with Northwestern University · NCT07230964
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 6
- US sites recruiting
- 1
- Study start
- April 30, 2026
- Record last updated
- May 5, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to evaluate the effectiveness of impedance cardiography (ICG), the HYPERGRAPH test, in detecting left ventricular decompensation in patients with aortic stenosis, compared to cardiac magnetic resonance (CMR) imaging findings. The study aims to obtain usable ICG test data on six patients with aortic stenosis who have recently undergone CMR scans with late gadolinium enhancement, and who do not have a history of myocardial infarction or cardiac amyloidosis. The hypothesis to be tested is that the HYPERGRAPH can accurately detect left ventricular decompensation associated with replacement fibrosis obtained from CMR imaging.
Being studied: Impedance Cardiography Upright/Supine Test
Conditions: Aortic Stenosis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- • Male or female at least 18 years of age.
- No prior history of myocardial infarction or cardiac amyloidosis.
- Recent CMR scan with late gadolinium enhancement or scheduled for CMR scan with late gadolinium enhancement.
- A history of:
- Moderate aortic stenosis and no replacement fibrosis OR Moderate aortic stenosis and symptoms who has replacement fibrosis OR Severe aortic stenosis with replacement fibrosis prior to aortic valve replacement.
- Able to comprehend and provide informed consent in English.
- Participants must have intact, healthy skin at the electrode application sites.
Exclusion Criteria
- • Under 18 years of age
- Pregnant or breastfeeding women
- Unable to consent
- Prisoners
- History of myocardial infarction
- History of cardiac amyloidosis
- Patients with any metal or implant such as IUD, braces, metal fragments implants in the eye, pacemakers (especially Minute Ventilation pacemakers with the MV function activated) defibrillators, or any other electronic cardiac implant.
- Claustrophobic or afraid or small places.
- Severe obesity (BMI > 40) that impairs accurate ICG measurement due to difficulties in electrode placement or excessive impedance.
- Active skin conditions, such as rashes, open wound or significant skin sensitivity at the electrode placement sites.
Recruiting US locations
Northwestern University
Chicago, IL 60611
Site contact: Michael Markl, PhD · 312-926-5268 · mmarkl@northwestern.edu
Study contacts (from the official record)
- Arthur P DeMarzo, MSc · 1-630-668-4644 · ademarzo.dermed@att.net
Similar studies in Illinois
All heart & blood pressure studies in Illinois →- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Chicago, IL + 30 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Pfizer
- Location
- Chicago, IL + 27 other US sites
- Eligibility basics
- Ages 18–79
- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- Chicago, IL + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
AstraZeneca
- Location
- Champaign, IL + 151 other US sites
- Eligibility basics
- Ages 40+